Advances and Progress in Drug Design 2012
February 20 - 21, 2012(Ended)
Copthorne Tara Hotel
London, United Kingdom
London, United Kingdom
The Advances and Progress in Drug Design is a conference that covers topics such as:
- Six Sigma - a tool to enhance drug design
- Strategies to increase the clinical success of the product
- Novel targets in drug discovery
- Protein-protein interactions
- Computational tools for reducing drug toxicity
- The latest in rational drug design
- Opportunities in outsourcing drug design
The Advances and Progress in Drug Design brings together VPs, Directors, Senior Managers, Heads, Biotech, Principal Scientists in Pharmaceutical and Academics from:
- Structure and Informatics
- Outsourcing
- Computational Chemistry
- Computer-aided Drug Design
- Cancer Pharmacology
- Cancer Research
- Pharmacology
- Medicinal Chemistry
- Drug Discovery & Design
- Molecular Imaging
- Molecular Discovery
- Target Discovery
- Target Discovery
- Drug Development
- Biophysics
- Translational Sciences
- Structural Biology
- Clinical Development
Venue
Address
Scarsdale Place, Kensington,
London,
United Kingdom
London,
United Kingdom
Prices *
1399 Pound Sterling
Organization
Categories
Concurrent events
- SES London 2012 - London
- World Generic Medicines Congress Europe 2012 - London
- Retail Shopfitting & Display Summit 2012 - London
- Objective Capital Americas Resources Congress 2012 - London
- Global Nuclear Supply Chain & Enhancement Forum (GNSCE 2012) - London
- Workplace Futures 2012 - London
- Turing lecture 2012 - London
- Immunogenicity for Biologics 2012 - London
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Past Events
Articles/News/Press releases
- Attending Health conferences is beneficial not only for professionals
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters.
- Validation of Palliative Prognostic Index for Terminal Cancer Patients in Hospice Consultation Setting in Taiwan
- Estimation of Serum Leptin Levels in Patients with chronic hepatitis C (CHC)
